World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
82647
World Ranking
3405
National Ranking
1875

John Crowley publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John Crowley sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 441 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John Crowley D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John Crowley sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 122 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 1991 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

John Crowley is affiliated with Washington University in St. Louis in the United States and has focused much of their research within the field of Medicine. Their main areas of study include Pulmonary and Respiratory Medicine, Surgery, Rheumatology, Oncology, and Genetics. The scientist's academic contributions span various topics, notably in Lung Cancer Treatments and Mutations, Statistical Methods in Clinical Trials, Bone Tumor Diagnosis and Treatments, Sarcoma Diagnosis and Treatment, Musculoskeletal synovial abnormalities and treatments, Dementia and Cognitive Impairment Research, as well as Health disparities and outcomes.

The scientist has published in several frequent venues, including:

  • Journal of Crohn s and Colitis
  • UNC Libraries
  • Skeletal Radiology
  • The Journal of Prevention of Alzheimer s Disease
  • Journal of Vascular and Interventional Radiology

Several recent papers highlight their contributions to medical research, including:

  • Percutaneous thermal ablation for treatment of osteoid osteoma: a systematic review and analysis (2020), published in Skeletal Radiology
  • Mental Component Score (MCS) from Health-Related Quality of Life Predicts Incidence of Dementia in U.S. Males (2021), published in The Journal of Prevention of Alzheimer s Disease
  • Society of Interventional Radiology Quality Improvement Standards for Percutaneous Nephrostomy in the Pediatric Population (2020), published in Journal of Vascular and Interventional Radiology
  • Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial (2025), published in The Lancet Respiratory Medicine
  • DOP64 Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn's Disease: Post hoc results from the phase 3b SEQUENCE trial (2024), published in Journal of Crohn s and Colitis

Crowley has collaborated frequently with other researchers, including:

  • David R. Gandara
  • Will S. Lindquester
  • C. Matthew Hawkins
  • Xiuhua Ding
  • Erin L. Abner

In recognition of their scientific contributions, John Crowley received the title of Fellow of the American Association for the Advancement of Science (AAAS) in 1991.

Best Publications

  • The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

    Peter Goldstraw;Kari Chansky;John Crowley;Ramon Rami-Porta

  • The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

    Peter Goldstraw;John Crowley;Kari Chansky;Dorothy J. Giroux

  • International staging system for multiple myeloma.

    Philip R. Greipp;Jesus San Miguel;Brian G.M. Durie;John J. Crowley

  • The Influence of Finasteride on the Development of Prostate Cancer

    Ian M. Thompson;Phyllis J. Goodman;Catherine M. Tangen;M. Scott Lucia

  • Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

    Ian M. Thompson;Donna K. Pauler;Phyllis J. Goodman;Catherine M. Tangen

  • International uniform response criteria for multiple myeloma

    B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade

  • Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

    Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia

  • Underrepresentation of patients 65 years of age or older in cancer-treatment trials.

    Laura F. Hutchins;Joseph M. Unger;John J. Crowley;Charles A. Coltman

  • Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

    Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley

  • The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

    Ramón Rami-Porta;David Ball;John Crowley;Dorothy J. Giroux

  • Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

    Charles D. Blanke;Cathryn Rankin;George D. Demetri;Christopher W. Ryan

  • National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

    Eifel P;Axelson Ja;Costa J;Crowley J

  • The molecular classification of multiple myeloma

    Fenghuang Zhan;Yongsheng Huang;Yongsheng Huang;Simona Colla;Simona Colla;James P. Stewart;James P. Stewart

  • Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

    Kathy S. Albain;Valerie W. Rusch;John J. Crowley;Thomas W. Rice

  • Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

    Hussein A Tawbi;Melissa Burgess;Vanessa Bolejack;Brian A Van Tine

  • A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

    John D. Shaughnessy;Fenghuang Zhan;Bart E. Burington;Yongsheng Huang

  • Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

    Kathy S. Albain;John J. Crowley;Michael LeBlanc;Robert B. Livingston

  • Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

    S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan

  • A Confidence Interval for the Median Survival Time

    Ron Brookmeyer;John Crowley

  • Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

    Ian M. Thompson;Donna Pauler Ankerst;Chen Chi;M. Scott Lucia

Frequent Co-Authors

Bart Barlogie
Bart Barlogie Mount Sinai Hospital
Frits van Rhee
Frits van Rhee University of Arkansas for Medical Sciences
John D. Shaughnessy
John D. Shaughnessy University of Arkansas for Medical Sciences
David R. Gandara
David R. Gandara University of California, Davis
Joshua Epstein
Joshua Epstein University of Arkansas for Medical Sciences
Elias Anaissie
Elias Anaissie University of Cincinnati
Maurizio Zangari
Maurizio Zangari University of Arkansas for Medical Sciences
Brian G.M. Durie
Brian G.M. Durie Cedars-Sinai Medical Center
Saad Z. Usmani
Saad Z. Usmani Memorial Sloan Kettering Cancer Center
Robert B. Livingston
Robert B. Livingston University of Arizona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in flexible routes into medical professions, there are various online degree options to consider. Many accelerated MSN to DNP programs offer a streamlined path for nurses aiming to achieve a Doctor of Nursing Practice degree faster, which can be a significant advantage for career advancement.

Cost can be a barrier, so looking for the cheapest DNP programs can help reduce financial stress while maintaining educational quality. Students seeking the most efficient path may want to explore fast track medical programs, which are designed to allow entry into the healthcare workforce quickly.

Specialization is also possible with online degrees. For example, there are accelerated MSN psychiatric NP programs that prepare nurses for in-demand mental health specialties in less time. If you’re a working nurse, research the variety of accelerated MSN to DNP programs available to find one that fits your goals and schedule.

Best Scientists Citing John Crowley

Trending Scientists

Recently Published Articles